¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Death Domain Receptor Signaling Adaptor Proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® receptor ÇÑ±Û ¼ö¿ëü
¼³¸í   
  ¼¼Æ÷Áú³» ¶Ç´Â ¼¼Æ÷Ç¥¸é¿¡ Á¸ÀçÇϴ ºÐÀÚ±¸Á¶·Î¼­ Æ¯À̹°Áú°ú ¼±ÅÃÀûÀ¸·Î °áÇÕÇϸ砰áÇÕ¿¡ ÀÇÇØ Æ¯ÀÌÇÑ »ý¸®Àû ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÆéƼµåÈ£¸£¸ó, ½Å°æÀü´Þ¹°Áú, Ç׿ø, º¸Ã¼, ¸é¿ª±Û·ÎºÒ¸°¿¡ ´ëÇÑ ¼¼Æ÷Ç¥¸é ¼ö¿ëü¿Í ½ºÅ×·ÎÀ̵忡 ´ëÇÑ ¼¼Æ÷Áú³» ¼ö¿ëü°¡ ÀÖ´Ù.
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
¿µ¹® brain death ÇÑ±Û ³ú»ç
¼³¸í   
  ³ú±â´ÉÀÌ ¿ÏÀüÈ÷ Á¤ÁöµÇ¾î È¸º¹ ºÒ´ÉÇÑ »óÅÂ. ³úÀÇ ±â´É¿¡´Â ´ë³ú¹Ý±¸ÀÇ ±â´É À̿ܿ¡ ³ú°£ÀÇ ±â´Éµµ Æ÷ÇԵȴÙ. ³ú»ç´Â Àΰ£ÀÇ Á×À½°ú °°Àº ¶æÀÌ ¾Æ´Ï°í, º¸ÅëÀº ³ú»ç ´ÙÀ½¿¡ Á×À½ÀÌ ¿Â´Ù. ½ÉÀåÀ̽Ġ¼ö¼ú¿¡´Â °¡´ÉÇÑ ÇÑ ½Å¼±ÇÑ ½ÉÀåÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ½ÉÀå Á¦°øÀÚÀÇ Á×À½À» ³ú»ç·Î ±ÔÁ¤ÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ ÀÖ¾ú´Ù. 1968³â 8¿ù ¼¼°èÀÇ»çȸ ÃÑȸ¿¡¼­ Ã¤ÅõȠÀå±âÀ̽Ŀ¡ °üÇÑ ¼±¾ð(½Ãµå´Ï ¼±¾ð)¿¡¼­´Â ¨ç ½ÉÀå Á¦°øÀÚÀÇ Á×À½ÀÇ ÆÇÁ¤Àº ³úÆÄÃøÁ¤»óÀÇ ³úÆÄÀÇ Á¤Áö(³ú»ç)·Î °áÁ¤ÇؾߠÇÑ´Ù. ¨è Á¦°øÀÚÀÇ Á×À½À» È®ÀÎÇϴµ¥ µÎ¸íÀÌ»óÀÇ Àǻ簡 ÀÔÈ¸ÇØ¾ß Çϸç, ³ú»çÀÇ °áÁ¤¿¡ Âü¿©ÇÑ ÀÇ»ç´Â À̽ļö¼ú¿¡ °ü¿©Çؼ­´Â ¾È µÈ´Ù°í Çß´Ù. ±×·¯³ª ³úÆÄÃøÁ¤¸¸À¸·Î´Â ³úÁÙ±âÀÇ ±â´ÉÁ¤Áö¸¦ ÆÇÁ¤ÇÒ ¼ö ¾ø°í, ³ú»çÀÇ ÆÇÁ¤µµ Áúº´ÀÇ Á¾·ù³ª Áøµµ¿¡ µû¶ó ±âÁØÀÌ ´Þ¶óÁö¹Ç·Î ÆÇÁ¤±âÁØÀÇ °ËÅä°¡ ÇÊ¿äÇÏ´Ù. ³úÁ¾¾ç-³ú¿Ü»ó-Ç÷ÇàÀå¾Ö µî ³úÁúȯÀÇ Áõ·Ê¿¡¼­ º¸¸é ¨ç ±íÀº È¥¼ö, ¨è ¾çÂÊ µ¿°øÀÇ È®´ë ¹× µ¿°øÀÇ ºû¹Ý»ç¿Í °¢¸·¹Ý»çÀÇ ¼Ò½Ç, ¨é È£ÈíÀÇ Á¤Áö, ¨ê ³úÆÄÀÇ Æòźȭ, ¨ë Ç÷¾ÐÀÇ ±Þ°ÝÇÑ ÀúÇϿ͠±×¿¡ µû¸¥ ÀúÇ÷¾Ð µî ´Ù¼¸ °¡Áö Á¶°ÇÀÌ 6½Ã°£ ÈÄ¿¡µµ µ¿ÀÏÇÑ »óÅ¿¡ Àִ °Í µî ¿©¼¸°¡Áö Á¶°ÇÀÌ ÆÇÁ¤ ±âÁØÀÌ µÇ¾ú¾ú´Ù. ÇöÀç´Â °¡Àå °­·ÂÇÑ µ¿ÅëÀڱؿ¡ ´ëÇØ¼­µµ ÀüÇô ¾Æ¹«·± °¨¼ö¼º°ú ¹ÝÀÀ¼ºÀ» ³ªÅ¸³»Áö ¾Ê´Â 24½Ã°£¿¡ °ÉÄ£ È¥¼ö·Î¼­, Àڹ߿ ¶Ç´Â ÀÚ¹ßÈ£ÈíÀÌ ¾ø°í À¯¹ß¹Ý»ç°¡ ¼Ò½ÇµÇ°í ³úÀÇ Àü±âȰµ¿ÀÌ ¾ø¾îÁö´Â È¸º¹ºÒ°¡´ÉÇÑ ÀǽļҽÇÀ̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù.
¿µ¹® death ÇÑ±Û »ç¸Á, Á×À½, »ç
¼³¸í   
  1. »ý¸íȰµ¿ÀÌ Á¤ÁöµÇ¾î ´Ù½Ã ¿ø»óÅ·Πµ¹¾Æ¿ÀÁö ¾Ê´Â »ý¹°ÀÇ »óÅÂ. »îÀÇ Á¾¸»À» ¸»ÇÑ´Ù. ¿¹¸¦ µé¾î ¾Æ¸Þ¹Ù µîÀÇ ´Ü¼¼Æ÷ »ý¹°¿¡¼­´Â 2°³Ã¼·Î ºÐ¿­µÉ ¶§°¡ Á×À½À̶ó°í ¸»ÇÒ ¼ö ÀÖÀ»Áö ¸ð¸£³ª ´Ù¼¼Æ÷ »ý¹°¿¡ À־´Â ¼¼Æ÷ºÐ¿­Àº ´Ü¼øÇÑ ¼ºÀåÀÇ ÇÑ °úÁ¤ÀÌ´Ù. »ý¹°Àº »ý½Ä¼¼Æ÷¸¦ ¸Å°³·Î »ý¸íÀ» ¿µ¿øÈ÷ Á¸¼Ó½Ã۴ °ÍÀ̶ó°í º¼ ¼ö ÀÖ´Ù. Àΰ£À» Æ÷ÇÔÇÑ °íµîµ¿¹°¿¡ ÇÑÁ¤ÇÑ´Ù°í Çϸé Á×À½À̶õ ±× °³Ã¼¸¦ ±¸¼ºÇϴ ¸ðµç Á¶Á÷ ¼¼Æ÷ÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¶ó°í ¸»ÇÒ ¼ö ÀÖ´Ù. µû¶ó¼­, ±¹ºÎÀûÀΠÇÑ ºÎºÐÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¸¸À¸·Î´Â Á×À½À̶ó°í ÇÒ ¼ö ¾ø´Ù. 2. »ç¶÷ÀÌ Á×À½. »ç¶÷ÀÇ Á×À½Àº ³× °³ÀÇ Ãø¸éÀÌ ÀÖ´Ù. Áï ¨ç À°Ã¼Àû Á×À½(biological death), ¨è ½É¸®Àû Á×À½(psychological death), ¨é »çȸÀû Á×À½(social death), ¨ê ¹®È­Àû Á×À½(culture death)À¸·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù. Àΰ£ÀÇ ÀÏ»ýÀº ´ÜÁö »ý¸íÀÇ ¿¬Àå »Ó ¾Æ´Ï¶ó ÁúÀû Ãø¸é¿¡¼­ ½É¸®Àû, »çȸÀû, ¹®È­ÀûÀÎ Ãæ½ÇÇÔÀÌ ÇÊ¿äÇÏ´Ù. ±Ù³â¿¡ ÀÇ·á±â¼úÀÇ ´«ºÎ½Å ¹ß´Þ¿¡ µû¶ó¼­ ´õ¿í »ýȰÀÇ ÁúÀÌ Áß¿ä½ÃµÇ°í ÀÖ´Ù. ÀϹÝÀûÀ¸·Î À°Ã¼ÀûÀΠÁ×À½ÀÇ Á¤ÀǴ ¸ðµç »ýü±â´ÉÀÇ ¿µ±¸Àû Á¤Áö. Áï ¨ç Àüü³ú±â´É, ¨è È£Èí°èÀÇ Àڹ߱â´É, ¨é ¼øÈ¯°èÀÇ Àڹ߱â´É, ÀÌ ¸ðµç °ÍÀÇ ºñ°¡¿ªÀûÀ¸·Î Á¤ÁöµÇ¾úÀ½À» ¸»ÇÑ´Ù.
¿µ¹® sudden infant death syndrome ÇÑ±Û ¿µ¾Æ±Þ»çÁõÈıº
¼³¸í   
  ÇÑ »ì ÀÌÇÏÀÇ °Ç°­ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀΠ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼­ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°­°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀΠ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adaptor
    1. ¿¬°á±â 2. À¯µµ°ü 3. ÀûÀÀ±â
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • matrix adaptor
    ¸ÅÆ®¸¯½ºÀûÇÕ±â
  • signaling oncogene
    ½ÅÈ£Á¾¾çÀ¯ÀüÀÚ
  • domain
    1. ¿µ¿ª, Á¤ÀÇ¿ª, ±¸¿ª 2. µµ¸ÞÀÎ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • magnetic domain
    Àڱⱸ¿ª
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • apparent death
    °¡»ç, °Ñº¸±â»ç¸Á
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°»ç¸Á·ü
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adaptor
    ¿¬°á±â, À¯µµ°ü, ÀûÀÀ±â
  • domain
    ¿µ¿ª
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor
    ¼ö¿ëü, ¼ö¿ë±â
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • sensory receptor
    °¨°¢¼ö¿ëü
  • receptor site
    ¼ö¿ëüºÎÀ§
  • death
    »ç¸Á, Á×À½, »ç
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • apparent death
    °¡»ç
  • brain death
    ³ú»ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • sudden cardiac death
    ±Þ¼º½ÉÀå»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adaptor
    ¿¬°á±â, À¯µµ°ü, ÀûÀÀ±â
  • matrix adaptor
    ¸ÅÆ®¸¯½ºÀûÇÕ±â
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • signaling oncogene
    ½ÅÈ£Á¾¾çÀ¯ÀüÀÚ
  • domain
    µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª, ¿µ¿ª
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • magnetic domain
    Àڱ⿵¿ª, ÀÚ¼º¿µ¿ª
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°Æ¯¼ö»ç¸Á·ü
  • apparent death
    °¡»ç
  • death registration area
    »ç¸Áµî·ÏÁö¿ª
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • brain death
    ³ú»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª.
  • Y-adaptor
    Y-¾Æ´äŸ, YÇü¿¬°á°ü.
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.¼Ò¾ÆÀ¯µµ°ü.
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.[¼Ò¾Æ]À¯µµ°ü.
  • G-proteins
    G-´Ü¹é(Ó±ÛÜ)
  • g proteins
    G ´Ü¹é
  • g-proteins
    G´Ü¹éÁú
  • guanosine triphosphate(gtp)-bindting proteins
    »ïÀλ걸¾Æ³ë½Å°áÇմܹéÁú
  • Death and dying
    »ç¸Á°úÀÓÁ¾
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accidental death
    »ç°í»ç, ÀçÇØ»ç .
  • accidental death
    »ç°í»ç(ÞÀͺÞÝ)
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.[¼Ò¾Æ]À¯µµ°ü.
  • adapter =adaptor
    ¿¬°á±â<°ü>, ÀûÀÀ±â, ¾Æ´ðÅÍ, Á¢ÇÕ±â.¼Ò¾ÆÀ¯µµ°ü.
  • matrix adaptor
    ¸ÅÆ®¸¯½ºÀûÇÕ±â(¡­îêùêÐï).
  • second signaling
    Á¦À̽ÅÈ£°è.
  • signaling
  • signaling oncogenes
    ½ÅÈ£ Á¾¾çÀ¯ÀüÀÚ
  • signaling pathway, interneuronal
    ½Å°æ¼¼Æ÷°£ ½ÅÈ£Àü´Þ°æ·Î
  • g proteins
    G ´Ü¹é
  • g-proteins
    G´Ü¹éÁú
  • glycosyl phosphatidyl inositol-linked proteins
    Glycosyl phosphatidyl inositol-linked proteins
  • guanosine triphosphate(gtp)-bindting proteins
    »ïÀλ걸¾Æ³ë½Å°áÇմܹéÁú
  • stress proteins
    ½ºÆ®·¹½º´Ü¹éÁú(¡­Ó±ÛÜòõ)
  • domain
    µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª
  • domain
    ¿µ¿ª(ÖÅæ´)
  • domain
    ¿µ¿ª(ËçËç).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Prenatal death
    Ãâ»ýÀü»ç¸Á
    [¿¾ ¿ë¾î] Ãâ»ýÀü»ç¸Á
  • Receptor
    ¼ö¿ë±â
    [¿¾ ¿ë¾î] ¼ö¿ë±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adaptor
    ¾Æ´äÅÍ
  • adaptor RNA
    ¾Æ´äÅÍ RNA
  • domain
    ¿µ¿ª(ÖÅæ´)
  • mononucleotide binding domain
    ¸ð³ë´©Å¬·¹¿ÀŸÀÌµå °áÇÕ¿µ¿ª(Ì¿ùêÖÅæ´)
  • nucleotide-binding domain
    ´©Å¬¸®¿ÀŸÀÌµå °áÇÕ¿µ¿ª(Ì¿ùêÖÅæ´)
  • protein domain
    ´Ü¹éÁú ¿µ¿ª(Ó±ÛÜòõÖÅæ´)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • reproductive death
    Àç»ý ºÒ´É»ç(î¢ßæÝÕÒöÞÝ)
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal death time
    ¿­»ç½Ã°£ (æðÞÝãÁÊà)
  • thymineless death
    ŸÀ̹ΰῩ»ç (ÌÀåýÞÝ)
  • bundling proteins
    ±Ù¼Ó´Ü¹éÁú(ÐÉáÖÓ±ÛÜòõ)
  • capping proteins
    ĸÇü¼º(û¡à÷) ´Ü¹éÁú(Ó±ÛÜòõ)
  • extrinsic proteins
    ¿ÜÀÎ ´Ü¹éÁú (èâì×Ó±ÛÜòõ)
  • high-quality proteins
    °í±Þ ´Ü¹éÁú(ÍÔÐäÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
  • domain
    ¿µ¿ª, µµ¸ÞÀÎ, Á¤ÀDZ¸¿ª
  • magnetic domain
    Àڱ⿵¿ª
  • death
    Á×À½, »ç¸Á
  • fetal death
    žƻç¸Á
  • sudden death
    ±Þ»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LESTR leukocyte-derived seven-transmembrane domain receptor
PBPs Penicillin-Binding Proteins
PVM pneumonia virus of mice; proteins, vitamins, and minerals
RPSP reference preparation for serum proteins
SIDS Sudden Infant Death Syndrome; ¿µ¾Æ µ¹¿¬»ç ÁõÈıº
  = Crib Death
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DISC death inducing signaling complex
RGS proteins Regulators of G protein signaling
AP adaptor protein
DED death effector domain
FADD FAS-associated death domain protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • matrix adaptor
    ¸ÅÆ®¸¯½º ÀûÇÕ±â
  • domain structure
    ¿µ¿ª ±¸Á¶
  • salivary domain
    Ÿ¾× ¿µ¿ª
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • adjusted death rate
    Á¶Á¤ »ç¸Á·ü
  • black death
    Èæ»çº´
  • bone marrow death
    °ñ¼ö »ç
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • cell death
    ¼¼Æ÷»ç
    ¼¼Æ÷°¡ Á׾´Â °úÁ¤¿¡¼­ »ýü ÀÛ¿ëÀÌ ¼¼Æ÷ ¼öÁØ¿¡¼­ Áß´ÜµÈ ÁöÁ¡. ¼¼Æ÷»ç´Â Á¶Á÷À̳ª Àå±â¸¦ Àå±â ÀÌ½Ä °ø¿©Ã¼·Î »ç¿ëÇÏ´Â °Í¿¡ ¾Õ¼­ ÀϾ´Ù.
  • death certificate
    »ç¸ÁÁø´Ü¼­, ½Ãü°Ë¾È¼­
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • death wound
    Ä¡¸í»ó
    Á×À½ÀÇ ¿øÀÎÀÌ µÈ »óó.
  • electric death
    °¨Àü»ç
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • immediate death
    Áï»ç, ¼ø°£»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
clathrin adaptor proteins <cell biology> Family of proteins that bind to clathrin and promote its assembly into vesicle coats. Different adaptor proteins are associated with coated vesicles of Golgi or plasma membrane origin.
(18 Nov 1997)
second signaling system <psychology> Pavlovian term for speech in which words are considered to be the second signals capable of producing conditioned responses.
(05 Mar 2000)
hydrophilic signaling molecule <molecular biology> A type of molecule which, because it is easily dissolved in water (it is hydrophilic), can easily move through cell membranes and thus can be secreted from one cell and move into a target cell where it triggers a particular event. Many hormones and growth factors are hydrophilic signaling molecules.
(09 Oct 1997)
adaptor <molecular biology> Short synthetic oligonucleotide strands that have one stickyend and oneblunt end, the blunt ends join to the blunt end of a DNA fragment, forming a new fragment with two sticky ends that can be more easily spliced into a vector.
(13 Oct 1997)
adaptor hypothesis A hypothesis, proposed by F.H.C. Crick, that an adaptor molecule must be present between the information-containing DNA and the protein being synthesised.
(05 Mar 2000)
apple domain <molecular biology> A consensus sequence, composed of 90 amino acids including 6 cysteines, that forms a characteristic, vaguely apple shaped, pattern via disulphide bridges. Shared by plasma kallikrein and coagulation factor XI, both serine proteases.
(18 Nov 1997)
carboxy-terminal domain kinase <enzyme> Protein kinase that phosphorylates the c-terminal repeat domain of the largest subunit of RNA polymerase II at serine residues
Registry number: EC 2.7.1.-
Synonym: ctd kinase, hs-ctd kinase, tfiih-associated ctd kinase
(26 Jun 1999)
paired box domain <molecular biology> Conserved domain of 128 amino acids, found in several developmentally regulated proteins in Drosophila (for example paired, gooseberry, Pox), mouse and human (for example Pax, HuP1, HuP48).
(18 Nov 1997)
POU domain <molecular biology> A conserved protein domain of around 150 amino acids, composed of a 20 amino acid homeobox domain and a larger POU specific domain and so is the target of some transcription factors.
Named POU (Pit Oct Unc) after 3 such proteins: Pit 1 regulates expression of certain pituitary genes, Oct 1 and 2, that bind an octamer sequence in the promoters of histone H2A and some immunoglobulin genes and Unc 86, involved in nematode sensory neuron development.
(31 Dec 1997)
SH3 domain-containing proline-rich kinase <enzyme> A protein kinase which both phosphorylates ser and thr residues and has an sh3 domain; contains 847 amino acid residues; mol mass 92,688 da; genbank u07747
Registry number: EC 2.7.10.-
Synonym: src-homology 3 domain-containing proline-rich kinase, sprk protein, sprk gene product
(26 Jun 1999)
dinucleotide domain A structural domain in certain proteins that binds NAD+ or NADP+.
Synonym: dinucleotide domain.
(05 Mar 2000)
domain <molecular biology> Used to describe a part of a molecule or structure that shares common physico chemical features, for example hydrophobic, polar, globular, helical domains or properties for example DNA binding domain, ATP binding domain.
(18 Nov 1997)
EGF like domain Region of 30-40 amino acids containing 6 cysteines found originally in EGF and also in a range of proteins involved in cell signalling.
Examples: TGF _, amphiregulin, urokinase, tissue plasminogen activator, complement C6 C9, fibronectin, laminin (each subunit at least 13 times), nidogen, selectins. It is also found in the Drosophila gene products: Notch (36 times) Delta, Slit, Crumbs, Serrate.
(18 Nov 1997)
exit domain <molecular biology> One of the two main binding sites on the ribosome molecule. The finished portion of the polypeptide being translated is attached to this site and leaves the ribosome from this site when the entire polypeptide is finished.
(09 Oct 1997)
frequency domain The expression of a function by its amplitude and phase at each component frequency, usually as determined by Fourier analysis.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Death Domain Receptor Signaling Adaptor Proteins - »õâ Intracellular signaling adaptor proteins that bind to the cytoplasmic death domain region found on DEATH DOMAIN RECEPTORS. Many of the proteins in this class take part in intracellular signaling from TUMOR NECROSIS FACTOR RECEPTORS.
    Synonyms : DED Signaling Adaptor Proteins, DISC (Death Inducing Signaling Complex), Death Effector Domain Signaling Adaptor Proteins, Death Inducing Signaling Complex Proteins, Fas-DISC Components, fas Death-Inducing Signaling Complex Components, Fas DISC Components
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adaptor
    °¢»öÀÚ
  • signaling
    ½ÅÈ£¹ý
  • adaptor
    °¢»öÀÚ;°¡°¨ÀåÄ¡
  • receptor
    ¼ö¿ë±â;°¨°¢±â°ü;¼ö¿ëü
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
  • signaling
    ½ÅÈ£
  • domain
    ¿µÅä;¿µ¿ª;ÅäÁö;°³ÀÎ ¼ÒÀ¯Áö;¹üÀ§;º¯¿ª;¿µ¿ª;ÀÚ±¸
  • eminent domain
    (¹ý)ÅäÁö ¼ö¿ë±Ç
  • magnetic domain
    (°­ÀÚ¼ºÃ¼ÀÇ) ÀÚ±¸
  • public domain
    (ÁÖ³ª Á¤ºÎÀÇ)°øÀ¯Áö(in the public domain(ÀúÀÛ±Ç Æ¯Çã±Ç ¼Ò¸ê¿¡ ÀÇÇØ)ÀÚÀ¯·Î »ç¿ëÇÒ ¼ö ÀÖ´Â)
  • public domain
    °øÀ¯Áö;ÀÚÀ¯·Î »ç¿ëÇÒ ¼ö ÀÖ´Â
  • death
    Á×À½,Àü¸ê,»çÇü
  • Death Valley
    µ¥½º ¹ë¸®;Á×À½ÀÇ °è°î
  • black death
    Èæ»çº´;Æä½ºÆ®
  • cerebral death
    ³ú»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á